miRNA expression profile of colon cancer stem cells compared to non-stem cells using the SW1116 cell line

Oncology Reports

Volumn 28, Issue 6, 2012, Pages 2115-2124

  Fang, Yantian ^a   Xiang, Jianbin ^a   Chen, Zongyou ^a   Gu, Xiaodong ^a   Li, Zhengyang ^a   Tang, Feng ^a   Zhou, Zhongwen ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Colon cancer; Gene ontology; MicroRNA; Stem cell

Indexed keywords

CD133 ANTIGEN; CYTOSKELETON PROTEIN; HERMES ANTIGEN; MESSENGER RNA; MICRORNA; MICRORNA 29A; MICRORNA 29B; MICRORNA 449B; MICRORNA 4524; UNCLASSIFIED DRUG;

BIOINFORMATICS; CANCER CELL; CANCER RECURRENCE; CANCER STEM CELL; CELL ADHESION; CELL CYCLE; CELL DIFFERENTIATION; CELL ISOLATION; CELL LINE; CELL POPULATION; CELL STRAIN SW1116; COLON ADENOCARCINOMA; COLON CANCER; COMPARATIVE STUDY; CONFERENCE PAPER; DOWN REGULATION; EXTRACELLULAR MATRIX; FLOW CYTOMETRY; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE TARGETING; HUMAN; HUMAN CELL; HUMAN TISSUE; METASTASIS; MICROARRAY ANALYSIS; PHENOTYPE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; UPREGULATION;

ADENOCARCINOMA; ANTIGENS, CD; ANTIGENS, CD44; CELL CYCLE; CELL DIFFERENTIATION; CELL LINE, TUMOR; COLONIC NEOPLASMS; CYTOSKELETON; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GLYCOPROTEINS; HUMANS; MICRORNAS; NEOPLASTIC STEM CELLS; PEPTIDES; RNA, MESSENGER; SIGNAL TRANSDUCTION;

EID: 84868131659     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2012.2054     Document Type: Conference Paper

References (28)

1. Jemal A, Murray T, Ward E, et al: Cancer statistics. CA Cancer J Clin 59:225-249, 2009.
2. Lengauer C, Kinzler K and Vogelstein B: Genetic instabilities in human cancers. Nature 396:643-649, 1998. (Pubitemid 29003936)
3. Baylin S and Ohm J: Epigenetic gene silencing in cancer - a mechanism for early oncogenic pathway addiction? Nat Rev Cancer 6:107-116, 2006. (Pubitemid 43361543)
4. Esteller M: Cancer epigenomics: DNA methylomes and histonemodification maps. Nat Rev Genet 8:286-298, 2007. (Pubitemid 46439286)
5. Huang E and Wicha M: Colon cancer stem cells: implications for prevention and therapy. Trends Mol Med 14:503-509, 2008.
6. Pardal R, Clarke M and Morrison S: Applying the principles of stem-cell biology to cancer. Nat Rev Cancer 3:895-902, 2003. (Pubitemid 37500174)
7. Tan B, Park C, Ailles L and Weissman I: The cancer stem cell hypothesis: a work in progress. Lab Invest 86:1203-1207, 2006. (Pubitemid 44789910)
8. Chen Y, Hsu H, Chen Y, et al: Oct-4 expression maintained cancer stem-like properties in lung cancer-derived CD133-positive cells. PLoS One 3:e2637, 2008.
9. Gangemi R, Griffero F, Marubbi D, et al: SOX2 silencing in glioblastoma tumor-initiating cells causes stop of proliferation and loss of tumorigenicity. Stem Cells 27:40-48, 2009.
10. Todaro M, Alea M, Stefano DA, et al: Colon cancer stem cells dictate tumor growth and resist cell death by production of interleukin-4. Cell Stem Cell 1:389-402, 2007. (Pubitemid 47506537)
11. Bartel DP: MicroRNAs: genomics, biogenesis, mechanism and function. Cell 116:281-297, 2004.
12. Gregory RI, Yan K P, Amuthan G, et al: The microprocessor complex mediates the genesis of microRNAs. Nature 432:235-240, 2004. (Pubitemid 39545855)
13. Bernstein E, Caudy A, Hammond SM and Hannon GJ: Role for a bidentate ribonuclease in the initiation step of RNA interference. Nature 409:363-366, 2001. (Pubitemid 32151243)
14. Ambros V: The functions of animal microRNAs. Nature 431:350-355, 2004. (Pubitemid 39265675)
15. Meister G and Tuschl T: Mechanisms of gene silencing by double-stranded RNA. Nature 431:343-349, 2004. (Pubitemid 39265674)
16. Peters L and Meister G: Argonaute proteins: mediators of RNA silencing. Mol Cell 26:611-623, 2007. (Pubitemid 46856239)
17. Harfe BD, McManus M, Mansfield JH, Hornstein E and Tabin CJ: The RNaseIII enzyme Dicer is required for morphogenesis but not patterning of the vertebrate limb. Proc Natl Acad Sci USA 102:10898-10903, 2005. (Pubitemid 41105964)
18. Murchison E P, Stein P, Xuan Z Y, et al: Critical roles for Dicer in the female germline. Genes Dev 21:682-693, 2007. (Pubitemid 46440290)
19. Wang Y, Medvid R, Melton C, Jaenisch R and Blelloch R: DGCR8 is essential for microRNA biogenesis and silencing of embryonic stem cell self-renewal. Nat Genet 39:380-385, 2007. (Pubitemid 46328490)
20. Wienholds E, Koudijs MJ, Eeden F, Cuppen E and Plasterk R: The microRNA-producing enzyme Dicer1 is essential for zebrafish development. Nat Genet 35:217-218, 2003. (Pubitemid 37363173)
21. Li J, Chen YX, Zhao JF, Kong FR and Zhang YD: miR-203 reverses chemoresistance in p53-mutated colon cancer cells through downregulation of Akt2 expression. Cancer Lett 304:52-59, 2011.
22. Strillacci A, Griffonia C, Sansone P, et al: MiR-101 downregulation is involved in cyclooxygenase-2 overexpression in human colon cancer cells. Exp Cell Res 315:1439-1447, 2009.
23. Li P, Lu XM, Wang YY, et al: MiR181-b suppresses proliferation of and reduces chemoresistance to temozolomide in U87 glioma stem cells. J Biomed Res 24:436-443, 2010.
24. + cancer cells. Biochem Pharmacol 81:783-792, 2011.
25. Zhang HL, Li WH, Nan FF, et al: MicroRNA expression profile of colon cancer stem-like cells in HT29 adenocarcinoma cell line. Biochem Biophys Res Commun 404:273-278, 2011.
26. Seger R and Krebs EG: The MAPK signaling cascade. FASEB J: 72 6-735, 1995.
27. Polakis P: Wnt signaling and cancer. Genes Dev 14:1837-1851, 2000. (Pubitemid 30639518)
28. Kasper G, Mao L, Geissler S, Draycheva A, Trippens J, Kühnisch J, Tschirschmann M, Kaspar K, Perka C, Duda GN and Klose J: Insights into mesenchymal stem cell aging: involvement of antioxidant defense and actin cytoskeleton. Stem Cells 27:1288-1297, 2009.